LifeCell is a biotechnology company that develops and sells tissue grafts and blood cell preservation products including their human tissue product AlloDerm. AlloDerm is used during surgeries ranging from complex hernia repairs to breast reconstruction. It is also used in reconstructive plastic, dental, and burn surgeries and Strattice Reconstructive Tissue Matrix, for plastic and reconstructive surgery and wound healing.
AlloDerm patch failures can cause damage to organs, tissue, and blood vessels near the patch. If you or a loved one has had surgery using the AlloDerm patch, please read on for facts about the product and the litigation surrounding it.
Facts about AlloDerm:
- The patches have a high rate of failure and increase the risk of complications in those who have had hernia repair surgery.
- Problems reported to the FDA include mesh explants, mesh failure, mesh tears, defective mesh, mesh perforations, adhesion issues, and mesh erosion.
- Patients with AlloDerm have side effects such as swelling, pain, abscess, inflammation, soreness, post-operative bulginess, hernia recurrence, and infection. In some cases, an additional surgery is required to remove the tissue/mesh.
- In 2011, the New Jersey Supreme Court designated the Alloderm cases for centralized management and assigned them to Judge Mayer.
If you have had a surgery using the AlloDerm patch and suffer from any of the post-operative issues listed above, find out how Johnson//Becker PLLC can help you. Fill out our case review form here on our website and submit it for a free consultation.